|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113 IDR | -4.24% |
|
-14.39% | -90.13% |
| May. 10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| Mar. 15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Pyridam Farma Tbk reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was IDR 164,862.3 million compared to IDR 172,441.56 million a year ago. Net loss was IDR 12,312.1 million compared to net income of IDR 2,496 million a year ago.
Basic loss per share from continuing operations was IDR 23.01 compared to basic earnings per share from continuing operations of IDR 4.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.13% | 77.91M | |
| +44.88% | 749B | |
| +39.02% | 605B | |
| -6.37% | 351B | |
| +19.92% | 328B | |
| +7.98% | 292B | |
| +11.78% | 216B | |
| -2.49% | 214B | |
| +1.93% | 167B | |
| +7.34% | 165B |
PT PYRIDAM FARMA TBK 
